ASGR1 and colonic neoplasm: Carbohydrate-mediated targeting was further demonstrated in galactosylated CS-functionalized MSNPs, which achieved selective cytotoxicity toward HT-29 colon cancer cells via ASGPR recognition, while exhibiting reduced toxicity toward normal fibroblasts [71].